Anne Favret, MD, discusses the importance of clinical trials in the breast cancer space.
Anne Favret, MD
Advertisement
Articles by Anne Favret, MD
Anne Favret, MD, discusses the evolution of treatment in HER2-positive breast cancer.
Advertisement
Latest Updated Articles
Dr. Favret on the Evolution of Treatment in HER2+ Breast CancerPublished: May 4th 2020 | Updated:
Dr. Favret on Extending Survival and Improving Outcomes in Breast CancerPublished: June 4th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5